Cargando…
A comparative analysis of international health technology assessments for novel gene silencing therapies: patisiran and inotersen
OBJECTIVES: Using the case study of patisiran and inotersen, we conducted a narrative comparative analysis of the health technology assessment (HTA) agency appraisals of these two first-in-class transthyretin gene silencers, which represent exceptional advances in the treatment of hereditary transth...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AboutScience
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616187/ https://www.ncbi.nlm.nih.gov/pubmed/36627862 http://dx.doi.org/10.33393/grhta.2021.2193 |